WO2000041640A1 - Dispositif medical pour augmenter le debit chez des patients souffrant d'atteintes par occlusions des arteres cerebrales, et procedes d'utilisation de ce dispositif - Google Patents

Dispositif medical pour augmenter le debit chez des patients souffrant d'atteintes par occlusions des arteres cerebrales, et procedes d'utilisation de ce dispositif Download PDF

Info

Publication number
WO2000041640A1
WO2000041640A1 PCT/US2000/000478 US0000478W WO0041640A1 WO 2000041640 A1 WO2000041640 A1 WO 2000041640A1 US 0000478 W US0000478 W US 0000478W WO 0041640 A1 WO0041640 A1 WO 0041640A1
Authority
WO
WIPO (PCT)
Prior art keywords
tubular member
artery
carotid
port
lumen
Prior art date
Application number
PCT/US2000/000478
Other languages
English (en)
Inventor
Denise Barbut
Original Assignee
Coaxia, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coaxia, Inc. filed Critical Coaxia, Inc.
Publication of WO2000041640A1 publication Critical patent/WO2000041640A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1011—Multiple balloon catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3613—Reperfusion, e.g. of the coronary vessels, e.g. retroperfusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32—Surgical cutting instruments
    • A61B17/3205—Excision instruments
    • A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/369—Temperature treatment

Definitions

  • the present invention generally relates to medical devices useful in treating patients with acute stroke or occlusive cerebrovascular disease. More specifically, the invention provides an extra/intracranial device capable of removing blood from a peripheral artery or symptomatic carotid artery and returning the blood to the contralateral carotid artery, thereby providing a means of augmenting the collateral vasculature and maintaining perfusion distal to the offending lesion.
  • the device may employ neuroprotective agents, hypothermic perfusion, and an atherectomy device or an extracorporeal pumping mechanism to remove a vascular occlusion and reestablish cerebral perfusion.
  • Stroke is the third most common cause of death in the United States and the most disabling neurologic disorder. Approximately 700,000 patients suffer from stroke annually. Stroke is a syndrome characterized by the acute onset of a neurological deficit that persists for at least 24 hours, reflecting focal involvement of the central nervous system, and is the result of a disturbance of the cerebral circulation. Outcome following stroke is influenced by a number of factors, the most important being the nature and severity of the resulting neurologic deficit. The patient's age, the cause of stroke, and coexisting medical illness also affect prognosis. Overall, less than 80% of patients with stroke survive for at least 1 month, and approximately 35% have been cited for the 10-year survival rates. Of patients who survive the acute period, up to 75% regain independent function, while approximately 15% require institutional care.
  • Hemorrhagic stroke accounts for 20% of the annual stroke population. Hemorrhagic stroke often occurs due to rupture of an aneurysm or arteriovenous malformation bleeding into the brain tissue, resulting in cerebral infarction. The remaining 80% of the stroke population are hemispheric ischemic strokes and are caused by occluded vessels that deprive the brain of oxygen-carrying blood. Ischemic strokes are often caused by emboli or pieces of thrombotic tissue that have dislodged from other body sites or from the cerebral vessels themselves to occlude in the narrow cerebral arteries more distally. When a patient presents with neurological symptoms and signs which resolve completely within 1 hour, the term transient ischemic attack
  • TIA ischemic hematoma
  • stroke a diagnostic hypothesis for the cause of stroke can be generated based on the patient's history, a review of stroke risk factors, and a neurologic examination. If an ischemic event is suspected, a clinician can tentatively assess whether the patient has a cardiogenic source of emboli, large artery extracranial or intracranial disease, small artery intraparenchymal disease, or a hematologic or other systemic disorder.
  • a head CT scan is often performed to determine whether the patient has suffered an ischemic or hemorrhagic insult. Blood would be present on the CT scan in subarachnoid hemorrhage, intraparenchymal hematoma, or intraventricular hemorrhage.
  • contraindications include the following: if the patient has had a previous stroke or serious head trauma in the preceding 3 months, if the patient has a systolic blood pressure above 185 mm Hg or diastolic blood pressure above 110 mmHg, if the patient requires aggressive treatment to reduce the blood pressure to the specified limits, if the patient is taking anticoagulants or has a propensity to hemorrhage, and/or if the patient has had a recent invasive surgical procedure. Therefore, only a small percentage of selected stroke patients are qualified to receive t-PA.
  • New devices and methods are thus needed in treating patients with acute ischemic stroke and occlusive cerebrovascular disease, in treating symptomatic patients with embolization or hemodynamic compromise, or in stroke prevention, e.g., patients with incidental finding of asymptomatic carotid lesion undergoing cardiothoracic surgery, which improve a patient's neurological function and quality of life without causing significant side effect, and can be used in patients with contraindication to using t-PA.
  • the invention provides devices and methods for treatment of acute ischemic stroke and occlusive cerebrovascular disease by taking advantage of the collateral cerebral circulation.
  • Anastomoses between the cerebral arteries provide alternative pathways in which blood can reach a given region of the brain besides the predominant supplying artery.
  • At the base of the brain close to the sella turcica, circulus arteriosus cerebri, or Circle of Willis, connects the vertebral and internal carotid arteries to each other and to the vessels of the opposite side.
  • occlusion of a blood vessel interrupting the flow of blood to a specific region of the brain occurs, survival of the brain tissue and therefore severity of a patient's neurological deficit depend on the number and size of its collateral arteries.
  • Effective stroke therapies therefore rely on the physicians' ability to respond to treatment quickly, since the longer the brain is deprived of blood flow, the greater the damage that occurs.
  • the devices and methods of the present invention are used to augment contralateral blood flow across the Circle of Willis to improve and maintain perfusion to an ischemic region distal to an occluded intra/extracranial cerebral artery, and thus can be utilized in stroke patients immediately after onset of symptoms to maintain viability of the cerebral tissue until the obstructing lesion is removed by an intervention or resolved with time (more than one half of the occluding thrombi usually lyse themselves in a few days) .
  • One embodiment of the medical device comprises first and second elongate tubes.
  • Each tube has a manometer at a distal end and a lumen communicating with a port at the distal end.
  • An expandable occlusive member is optionally mounted on either or both tubular members proximal to the distal port and is adapted to expand to engage the lumen of an intracranial or extracranial artery.
  • a proximal end of each tubular member attaches to an oxygenator or a pump for aspirating blood through the first tube and perfusing the blood through the second tube.
  • each tube has an additional lumen which communicates with a port distal to the balloon occluder for infusing fluid and pharmaceutical agents, such as a neuroprotective agent or heparin.
  • first and second tubes are carried within the lumen of an elongate catheter.
  • the lumen of either tubular member communicates with one or a plurality of perfusion ports and is adapted for aspiration or infusion of blood.
  • the proximal end of either tubular member includes a blood filter which entraps any thromboembolic debris flowing through the circuit before blood is perfused to an artery.
  • the first tubular member which is adapted for insertion into an occluded carotid or cerebral artery, comprises an additional lumen adapted for introduction of an atherectomy device for removing occlusive lesions in the artery. The invention also provides methods for augmenting contralateral circulation in a patient with occlusive cerebrovascular disease using the devices described above.
  • the methods can be used to perfuse and maintain blood flow to an ischemic region distal to an occluding lesion in patients who are symptomatic due to embolization of a cerebral artery lesion or hemodynamic compromise caused by the lesion.
  • the methods can also be used in stroke prevention, e.g., in asymptomatic patients who are undergoing a major surgery such as cardiothoracic surgery and are found incidentally to have significant flow limiting cerebral lesions during cardiac catheterization or angiogram.
  • the distal end of the first tubular member is inserted through an incision into a peripheral artery, such as a femoral artery.
  • a peripheral artery such as a femoral artery.
  • IVUS intravascular ultrasound
  • the distal end of the second tubular member is inserted through the same incision or a different incision into the contralateral carotid artery.
  • Oxygenated blood is aspirated from the artery through the lumen and port of the first tubular member and perfused into the contralateral carotid artery through the lumen and port of the second tubular member.
  • An expandable occluder e.g., a balloon occluder
  • a balloon occluder may be expanded on the second tubular member proximal to the distal port to control the flow rate more effectively.
  • augmented contralateral perfusion provides enhanced reversal of blood flow across the Circle of Willis to compensate for the sudden decrease of flow in the occluded artery.
  • the distal end of the first tubular member is inserted through an incision on a peripheral artery, such as a femoral artery, and advanced into the symptomatic carotid or cerebral artery proximal to the occluding lesion.
  • a peripheral artery such as a femoral artery
  • the device can also be inserted into a patient's carotid artery as a direct stick after localizing the occlusion with the assistance of IVUS or standard carotid doppler and/or transcranial doppler (TCD) .
  • TCD transcranial doppler
  • the distal end of the tubular member can be advanced as far as the occluding site which could be in the common carotid artery, internal carotid artery, middle cerebral artery, anterior cerebral artery, carotid siphon, terminal internal carotid artery, or any other part of the cerebral vasculature.
  • the distal end of the second tubular member is then inserted through the same incision or a different incision, and advanced into the contralateral carotid artery.
  • the balloon occluder mounted on the first tubular member proximal to the distal port is inflated to partially occlude the arterial lumen.
  • the proximal end of the first tubular member is attached to a vacuum pump and blood is aspirated from the symptomatic carotid artery through the lumen and port of the first tubular member, and delivered to the contralateral carotid artery through the lumen and port of the second tubular member.
  • the flow rate can be controlled by deflating or inflating the balloon, e.g., the flow rate increases as the balloon is deflated.
  • the augmented contralateral hemispheric blood flow which helps to reverse flow across the Circle of Willis, provides (1) retrograde arterial collateral enhancement to the ischemic area distal to the occlusion and (2) enhances the pressure differential across the occluding lesion, which may be sufficient to dislodge any thromboembolic material.
  • Blood aspirated from the symptomatic artery is, in certain embodiments, passed through a blood filter optionally included in the proximal end of the first or second tubular member or in the pump to entrap any embolic debris before the blood is returned to the contralateral carotid artery.
  • the devices can be used (1) in a majority of stroke patients, including those with contraindication to using systemic t-PA, (2) to administer neuroprotective agents locally into an occluded vessel, thereby providing greater local benefit and fewer systemic side effects, (3) to infuse hypothermic fluid or blood to the ischemic area, thereby providing protective focal hypothermia, (4) with standard atherectomy to remove arterial atheroma, (5) as an angioplasty device by inflating the balloon over the stenotic arterial lumen to enlarge the luminal diameter, (6) by any invasive radiologist or cardiologist, (7) in the angiogram or fluoroscopy suite available in most hospitals, (8) in treating acute stroke patients with few systemic side effects, (9) to treat symptomatic vertebral artery occlusion, (10) to maintain cerebral perfusion in patients with asymptomatic flow limiting carotid stenosis undergoing major cardiot
  • Fig. 1 depicts a normal cerebral circulation in the Circle of Willis.
  • Fig. 2 depicts a reversed circulation in the Circle of Willis to compensate for an occlusion in the left internal carotid artery.
  • Fig. 3A depicts an embodiment of the medical device for treatment of acute stroke according to the present invention.
  • Fig. 3B depicts the device shown in Fig. 3A inserted in the contralateral carotid artery.
  • Fig. 4 depicts another embodiment of the device inserted in the carotid artery to provide contralateral flow augmentation .
  • Fig. 5A depicts a distal region of another embodiment of the device for treatment of acute stroke.
  • Fig. 5B depicts the device of Fig. 5A inserted into bilateral carotid arteries.
  • Fig. 6 depicts a distal region of another embodiment of the device having a balloon occluder.
  • Fig. 7A depicts another embodiment of the device having two balloon occluders .
  • Fig. 7B depicts a proximal region of the device shown in Fig. 7A.
  • Fig. 7C depicts a distal region of the device in Fig. 7A inserted in the carotid arteries.
  • Fig. 8A depicts still another embodiment of the device having two balloon occluders and a plurality of perfusion ports on one of the tubular members.
  • Fig. 8B depicts still another embodiment of the device having balloon occluders and a plurality of perfusion ports on both tubular members .
  • Fig. 9 depicts the device of Fig. 8B inserted in the vertebral arteries.
  • Fig. 10 depicts different peripheral artery access sites for insertion of the device.
  • the cerebral circulation is regulated in such a way that a constant total cerebral blood flow (CBF) is generally maintained under varying conditions.
  • CBF total cerebral blood flow
  • a reduction in flow to one part of the brain, such as in acute stroke may be compensated by an increase in flow to another part, so that CBF to any one region of the brain remains unchanged.
  • the brain compensates by increasing blood flow to the ischemic area through its collateral circulation.
  • Fig. 1 depicts a normal cerebral circulation and formation of Circle of Willis.
  • Aorta 100 gives rise to right brachiocephalic trunk 82, left common carotid artery (CCA) 80, and left subclavian artery 84.
  • the brachiocephalic artery further branches into right common carotid artery 85 and right subclavian artery 83.
  • the left CCA gives rise to left internal carotid artery (ICA) 90 which becomes left middle cerebral artery (MCA) 97 and left anterior cerebral artery (ACA) 99.
  • ICA left internal carotid artery
  • MCA middle cerebral artery
  • ACA left anterior cerebral artery
  • Anteriorly, the Circle of Willis is formed by the internal carotid arteries, the anterior cerebral arteries, and anterior communicating artery 91 which connects the two ACAs .
  • the right and left ICA also send right posterior communicating artery 72 and left posterior communicating artery 95 to connect respectively with right posterior cerebral artery (PCA) 74 and left PCA 94.
  • PCA right posterior cerebral artery
  • the two posterior communicating arteries and PCAs, and the origin of the posterior cerebral from basilar artery 92 complete the circle posteriorly.
  • occluding lesion 70 occurs acutely, for example, in left internal carotid artery 90, as depicted in Fig. 2, blood flow in the right cerebral arteries, left external carotid artery 78, right vertebral artery 76, and left vertebral artery 77 increases, resulting in directional change of flow through the Circle of Willis to compensate for the sudden decrease of blood flow in the left internal carotid artery. Specifically, blood flow reverses in right posterior communicating artery 72, right PCA 74, and left posterior communicating artery 95.
  • Anterior communicating artery 91 opens, reversing flow in left ACA 99, and flow increases in the left external carotid artery, reversing flow along left ophthalmic artery 75, all of which contribute to flow in left ICA 90 distal to the occluding lesion to provide perfusion to the ischemic area distal to the occlusion.
  • Figs. 3A and 3B depict an embodiment of the device for treatment of hemispheric ischemia.
  • the device comprises first tubular member 1 and second tubular member 2.
  • the first tubular member has lumen 10 communicating with distal port 11 and proximal end 13 adapted for aspiration of blood.
  • the second tubular member has lumen 20 communicating with distal port 22 and proximal end 23 adapted for perfusion of blood.
  • the first and second tubular members are carried within a lumen of elongate catheter 33.
  • Manometer 30, communicating proximally with sensor attachment 31, is carried at distal end 24 of the second tubular member for measuring blood pressure at the distal end.
  • Proximal end 13 of the first tubular member and proximal end 23 of the second tubular member are adapted for attachment to a pump or oxygenator.
  • the device In using the device of Fig. 3A for treatment of hemispheric ischemia, the device is inserted through an incision on a peripheral artery, such as the left femoral artery shown in Fig. 3B.
  • a peripheral artery such as the left femoral artery shown in Fig. 3B.
  • distal end 24 of second tubular member 2 is advanced over a guide wire to position in the right carotid artery.
  • Distal end 14 of tubular member 1 can be positioned in the descending aorta, the subclavian, the axillary, the femoral, or the iliac artery as depicted in Fig.
  • Proximal end 13 and 23 are connected to pump 35, which aspirates blood from port 11 and lumen 10 of the first tubular member, delivering the blood through blood filter 36 included in pump conduit 37, and perfusing the blood to the right carotid artery through lumen 20 and port 22 of the second tubular member.
  • Heparin may be administered through either proximal end of the tubular members or the pump conduit to provide anticoagulation, thereby preventing thrombi forming in the circuit. In some instances, the pump may not be necessary.
  • Increasing blood flow in the right carotid artery results in augmented flow in the right cerebral arteries and the right vertebral artery, enhancing directional change of flow through the Circle of Willis to compensate for the sudden decrease of blood flow in the left internal carotid artery as described in Fig. 2.
  • This method is particularly useful in situations in which increasing ipsilateral perfusion cannot be accomplished, e.g., in vessels having near total or complete occlusion.
  • contralateral perfusion some improvement in a patient's neurologic function may be achieved.
  • Fig. 4 depicts another embodiment of the device inserted through two separate incisions on the left femoral artery.
  • Tubular members 1 and 2 may be inserted through the same incision or different incisions on the artery. Construction of this device and methods of using it are similar to those described in Fig. 3A except insofar as the tubular members are not carried within a lumen of a catheter.
  • This embodiment may be desirable in situations in which the first tubular member is inserted into a vein, such as the femoral, iliac, axillary or subclavian vein. Deoxygenated blood is aspirated through port 11 and lumen 14 and delivered to an oxygenator.
  • Oxygenated blood is then delivered to pump 35 and to the right carotid artery through lumen 20 and port 22 to provide contralateral perfusion augmentation to the ischemic cerebral tissue distal to occlusion 70.
  • Mild to moderate hypothermia at approximately 32 to 34 °C, can be introduced during the blood recirculation.
  • Neuroprotective agents administered to the contralateral carotid artery through lumen 20 and port 22, may reach the ischemic region more effectively.
  • Figs . 5A and 5B depict still another embodiment of the device, which comprises tubular members 1 and 2.
  • the first tubular member has lumen 10 communicating with distal port 11 and proximal end 13 adapted for aspiration of blood from a carotid or a cerebral artery.
  • the second tubular member has lumen 20 communicating with distal port 22 and proximal end 23 adapted for perfusion of blood to a carotid artery.
  • the first and second tubular members are carried within a lumen of elongate catheter 33.
  • Manometer 30 and manometer 40 are carried respectively at distal end 24 of the second tubular member and distal 14 of the first tubular member for measuring blood pressure at the distal end.
  • Blood filter 36 is included in the proximal end of the second tubular member to capture embolic debris.
  • the device In use, the device is inserted through an incision on the left femoral artery as shown in Fig. 5B.
  • the distal end of tubular member 1 is advanced over a guide wire into the left carotid artery until occluding lesion 70 is localized with dye, and the distal end is positioned proximal to the occlusion.
  • the device can be advanced as far as the occluding site which could be in the common carotid artery, internal carotid artery, middle cerebral artery, anterior cerebral artery, carotid siphon, terminal internal carotid artery, or any other part of the cerebral vasculature.
  • the device can also be inserted into a patient's carotid artery as a direct stick after localizing the occlusion with the assistance of IVUS or standard carotid doppler and transcranial doppler (TCD) .
  • TCD transcranial doppler
  • Proximal end 13 and 23 of the first and second tubular member respectively are attached to pump 35. Blood is aspirated from the occluded carotid artery through lumen 10 and port 11, and delivered to the contralateral carotid artery through lumen 20 and port 22 after it passes through blood filter 36 included in the proximal end of the second tubular member.
  • the perfusion rate is generally approximately between 7 and 800 cc/ in and up to 1.2 liters/min. Heparinization is generally required to prevent thrombi forming in the flow circuit. Any embolic debris is filtered with 100 to 200 micron filter 36 prior to reentry.
  • the augmented contralateral hemispheric blood flow which reverses flow across the Circle of Willis via ACA, posterior communicating, ophthalmic, and external carotid arteries, provides not only retrograde arterial collateral enhancement to the ischemic area distal to the occlusion, but also enhanced pressure differential across the occlusion, which may be sufficient to dislodge and thereby remove the occluding lesion or any embolic debris in the symptomatic artery.
  • the desired flow rate necessary to reverse flow across the Circle of Willis is modified according to the patient's physical examination, since the patient may develop "steal” symptoms.
  • blood flow may be reduced significantly to result in "steal syndrome,” similar to "subclavian steal syndrome” in which significant subclavian stenosis leads to blood flow reversal in the vertebral artery and is redirected away from the brain to the distal subclavian artery with physical activity of the ipsilateral arm.
  • Aspiration of blood is reduced or discontinued if ischemic symptoms ensue.
  • the embodiment depicted in Fig. 6 differs from the embodiment depicted in Fig. 5B in that balloon occluder 50, communicating with inflation lumen 51, is mounted on distal region 24 of the second tubular member proximal to port 22.
  • the balloon can be inflated to occlude the arterial lumen to reduce runoff of perfused blood and to provide compartmentalization for administration of pharmaceutical agents, such as a neuroprotective agent.
  • Figs. 7A and 7B depict, respectively, a distal and a proximal region of another embodiment of the device for treatment of acute stroke.
  • the device comprises first tubular member 1 and second tubular member 2.
  • the first and second tubular members are carried within a lumen of elongate catheter 33.
  • the first tubular member has lumen 10 communicating with distal port 11 and proximal end 13.
  • the second tubular member has lumen 20 communicating with distal port 22 and proximal end 23.
  • the proximal ends of both tubular members are connected to pump 35 for aspirating blood from the first tubular member and delivering it to the second tubular member through conduit 37.
  • Lumens 10 and 20 further communicate, respectively, with proximal ports 68 and 58, which can be used to administer heparin or neuroprotective agents.
  • Blood filter 36 is included in the proximal end of the first tubular member for capturing embolic material in the blood before returning to the second tubular member.
  • Manometer 30 communicating with sensor attachment 31 is carried at distal end 24 of the second tubular member for measuring blood pressure at the distal end.
  • manometer 40 communicating with sensor attachment 32 is carried at distal end 14 of the first tubular member.
  • Balloon occluder 50 communicating with inflation lumen 51 is mounted on the distal end of the second tubular member proximal to port 22.
  • balloon occluder 60 communicating with inflation lumen 61 is mounted on the distal end of the first tubular member proximal to port 11.
  • first tubular member 1 In use, distal end 14 of first tubular member 1 is inserted proximal to occluding lesion 70 in the left carotid artery and distal end 24 of second tubular member 2 is inserted in the right carotid artery as shown in Fig. 7C. Blood is aspirated from the occluded artery through port 11 and lumen 10 of the first distal member, passed through the blood filter included in the proximal end of the first tubular member, and returned to the contralateral artery through lumen 20 and port 22 via the pump.
  • Balloon 50 on the second tubular member can be inflated to (1) prevent run-off of the perfused blood, (2) control flow rate to the contralateral artery, e.g., the flow rate decreases as the balloon is deflated, and (3) provide complete compartmentalization for more efficacious administration of pharmacotherapy to the cerebral tissues.
  • An atherectomy device may be introduced through an additional lumen (not shown) included in the first tubular member to remove the occluding lesion.
  • Balloon 60 on the first tubular member can be inflated or deflated to (1) control the flow rate of aspirated blood, e.g., the flow rate increases as the balloon is deflated, (2) increase negative pressure proximal to the occlusion, thereby enhancing the pressure gradient across the occlusion, which may dislodge the offending lesion, and (3) assist in removing tissue or atheromatous debris generated during atherectomy, thereby reducing embolization to the distal arteries.
  • Figs. 8A and 8B depict 'still other embodiments of the device having a plurality of ports.
  • the embodiments comprise balloon occluders 50 and 60, communicating respectively with inflation lumen 51 and 61, mounted on first tubular member 1 and second tubular member 2.
  • lumen 10 of the first tubular member communicates with port 11 distally.
  • Lumen 20 of the second tubular member communicates with 1, 2, 3, 4, 5, 6, or other number of perfusion ports 66 distally to provide more efficient delivery of perfused blood to the contralateral carotid artery.
  • lumens 10 and 20 of the first and second tubular members communicate, respectively, with distal port 11 and 22, and with 1, 2, 3, 4, 5, 6, or other number of perfusion ports 66 distally; in which case the ports can be used to aspirate blood from the symptomatic carotid artery or perfuse blood to the contralateral carotid artery.
  • Emboli small enough to pass through the vertebral arteries into the larger basilar artery are usually arrested at the top of the basilar artery where it bifurcates into the posterior cerebral arteries .
  • the resulting reduction in blood flow to the ascending reticular formation of the midbrain and thalamus produces immediate loss or impairment of consciousness.
  • the devices and methods described above can be used to (1) maintain perfusion to an ischemic region by enhancing blood flow to the contralateral artery when ipsilateral perfusion can not be augmented, (2) remove thromboembolic material from the vertebral artery, or (2) provide protection during angioplasty and/or stenting by occluding the artery, reversing the flow and so preventing emboli from progressing through the basilar artery.
  • the occluding lesion is first localized with transcranial doppler or angiogram.
  • Distal end 14 of first tubular member 1 is shown inserted proximal to thromboembolic material 70 in right vertebral artery 87 as shown in Fig. 9.
  • Distal end 24 of second tubular member 2 is inserted in left vertebral artery 88.
  • distal end 14 can be inserted in the right brachiocephalic or the right subclavian artery, and distal end 24 can be inserted in the left subclavian or the left carotid artery.
  • Proximal ends of both tubular members are attached to a pump for aspirating blood from the occluded vertebral artery and returning to the contralateral vertebral artery.
  • Balloon occluders 50 and 60 can be inflated to control the flow rate.
  • distal end 24 can be inserted in the ipsilateral carotid artery when perfusion to the ischemic region via ipsilateral collaterals can be augmented.
  • suction By applying suction to the distal end of the first tubular member, the pressure gradient across the occluding lesion increases and thromboembolic material 70 may be dislodged onto the distal port and be removed.
  • Fig. 10 depicts different sites of entry for the devices disclosed herein.
  • An incision can be made on a peripheral artery, such as right femoral artery 122, left femoral artery 120, right radial artery 116, left radial artery 115, right brachial artery 112, left brachial artery 110, right axillary artery 126, left axillary artery 115, right subclavian artery 142, or left subclavian artery.
  • An incision can also be made on right carotid artery 132 or left carotid artery 130 in emergency situations.
  • the length of either tubular member will generally be between 10 and 200 centimeters, preferably approximately between 30 and 150 centimeters.
  • the inner diameter of the tubular member will generally be between 0.2 and 0.7 centimeters depending on the desired perfusion rate, preferably approximately between 0.3 and 0.5 centimeters.
  • the diameter of the expanded occluder will generally be between 0.3 and 2 centimeters, preferably approximately 0.5 and 1.0 centimeters.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Child & Adolescent Psychology (AREA)
  • External Artificial Organs (AREA)

Abstract

L'invention concerne un dispositif médical comprenant un premier et un second éléments tubulaires (1, 2). Chacun de ces éléments est pourvu d'un manomètre au niveau d'une extrémité distale, une lumière (10, 20) communiquant avec un orifice (11, 22) également au niveau de cette extrémité. De plus, un élément occlusif extensible est éventuellement monté sur l'un desdits éléments tubulaires, ou sur les deux, à proximité de l'orifice distal. L'extrémité proximale (13, 23) de chaque élément tubulaire (1, 2) est par ailleurs destinée à être reliée à un oxygénateur et/ou à une pompe (35), afin de pouvoir aspirer le sang d'une artère ou d'une artère carotide symptomatique à travers le premier élément tubulaire (1), de manière à irriguer le sang dans l'artère carotide controlatérale à travers le second élément tubulaire (2), ce qui permet une perfusion prolongée, même à l'écart d'une lésion (70), le débit pouvant être régulé par un dispositif d'occlusion à ballonnet. Le dispositif de cette invention peut notamment utiliser un agent neuro-protecteur, une perfusion hypothermique, ainsi qu'un dispositif d'athérectomie ou un mécanisme de pompage extra-corporel. Cette invention concerne également des procédés d'utilisation de ce dispositif pour traiter des patients ayant subi une attaque aiguë ou souffrant d'atteintes par occlusions des artères cérébrales.
PCT/US2000/000478 1999-01-15 2000-01-06 Dispositif medical pour augmenter le debit chez des patients souffrant d'atteintes par occlusions des arteres cerebrales, et procedes d'utilisation de ce dispositif WO2000041640A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/232,438 1999-01-15
US09/232,438 US6161547A (en) 1999-01-15 1999-01-15 Medical device for flow augmentation in patients with occlusive cerebrovascular disease and methods of use

Publications (1)

Publication Number Publication Date
WO2000041640A1 true WO2000041640A1 (fr) 2000-07-20

Family

ID=22873110

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/000478 WO2000041640A1 (fr) 1999-01-15 2000-01-06 Dispositif medical pour augmenter le debit chez des patients souffrant d'atteintes par occlusions des arteres cerebrales, et procedes d'utilisation de ce dispositif

Country Status (2)

Country Link
US (3) US6161547A (fr)
WO (1) WO2000041640A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1156848A1 (fr) * 1999-03-01 2001-11-28 Coaxia, Inc. Dispositifs et procedes d'occlusion aortique partielle pour augmenter l'irrigation sanguine cerebrale
WO2006026805A1 (fr) * 2004-09-07 2006-03-16 Droneon Pty Limited Dispositifs et systemes d'acces peripherique
AU2005282202B2 (en) * 2004-09-07 2010-09-09 Droneon Pty Limited Peripheral access devices and systems
US8888740B2 (en) 2001-04-24 2014-11-18 Zoll Circulation, Inc. Partial aortic occlusion devices and methods for cerebral perfusion augmentation
US9078982B2 (en) 2007-11-07 2015-07-14 Rodney J. Lane Systems, methods and devices for circulatory access

Families Citing this family (218)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050245894A1 (en) * 1996-05-20 2005-11-03 Medtronic Vascular, Inc. Methods and apparatuses for drug delivery to an intravascular occlusion
US20020169458A1 (en) * 1997-02-06 2002-11-14 Connors John J. ICA angioplasty with cerebral protection
US6610004B2 (en) * 1997-10-09 2003-08-26 Orqis Medical Corporation Implantable heart assist system and method of applying same
US6889082B2 (en) * 1997-10-09 2005-05-03 Orqis Medical Corporation Implantable heart assist system and method of applying same
US6736790B2 (en) * 1998-02-25 2004-05-18 Denise R. Barbut Method and system for selective or isolated integrate cerebral perfusion and cooling
US6423032B2 (en) * 1998-03-13 2002-07-23 Arteria Medical Science, Inc. Apparatus and methods for reducing embolization during treatment of carotid artery disease
US6908474B2 (en) * 1998-05-13 2005-06-21 Gore Enterprise Holdings, Inc. Apparatus and methods for reducing embolization during treatment of carotid artery disease
US6165199A (en) * 1999-01-12 2000-12-26 Coaxia, Inc. Medical device for removing thromboembolic material from cerebral arteries and methods of use
US6161547A (en) * 1999-01-15 2000-12-19 Coaxia, Inc. Medical device for flow augmentation in patients with occlusive cerebrovascular disease and methods of use
US6682505B2 (en) 1999-03-12 2004-01-27 Arteria Medical Science, Inc. Catheter for removing emboli from saphenous vein grafts and native coronary arteries
US6488671B1 (en) * 1999-10-22 2002-12-03 Corazon Technologies, Inc. Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same
WO2001043661A2 (fr) * 1999-12-14 2001-06-21 Radiant Medical, Inc. Technique permettant de limiter un infarctus du myocarde par application d'une hypothermie intravasculaire
US6719749B1 (en) 2000-06-01 2004-04-13 Medical Components, Inc. Multilumen catheter assembly and methods for making and inserting the same
US6695832B2 (en) 2000-06-01 2004-02-24 Twincath, Llc Multilumen catheter and methods for making the catheter
US6776770B1 (en) 2000-09-07 2004-08-17 Advanced Research & Technology Institute Thromboaspiration valve-filter device and methods
US6761700B2 (en) 2001-02-09 2004-07-13 Orqis Medical Corporation Extra-corporeal vascular conduit
US6595980B1 (en) * 2001-02-23 2003-07-22 Coaxia, Inc. Devices and methods for preventing distal embolization using flow reversal by occlusion of the brachiocephalic artery
US6830579B2 (en) 2001-05-01 2004-12-14 Coaxia, Inc. Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature
US7048680B2 (en) 2001-06-06 2006-05-23 Orqis Medical Corporation Multilumen catheter for minimizing limb ischemia
US20020188167A1 (en) * 2001-06-06 2002-12-12 Anthony Viole Multilumen catheter for minimizing limb ischemia
US6902540B2 (en) 2001-08-22 2005-06-07 Gerald Dorros Apparatus and methods for treating stroke and controlling cerebral flow characteristics
US20030040762A1 (en) * 2001-08-22 2003-02-27 Gerald Dorros Apparatus and methods for treating stroke and controlling cerebral flow characteristics
US7063714B2 (en) * 2001-08-22 2006-06-20 Gore Enterprise Holdings, Inc. Apparatus and methods for treating stroke and controlling cerebral flow characteristics
US6929634B2 (en) 2001-08-22 2005-08-16 Gore Enterprise Holdings, Inc. Apparatus and methods for treating stroke and controlling cerebral flow characteristics
EP2286866A3 (fr) 2001-08-22 2013-04-03 Gore Enterprise Holdings, Inc. Appareil et procédés permettant de traiter les accidents vasculaires cérébraux et de contrôler les caractéristiques du débit sanguin cérébral
US6848448B1 (en) 2002-01-23 2005-02-01 Coaxia, Inc. Devices and methods for cerebral perfusion augmentation
AU2003225532A1 (en) * 2002-01-24 2003-09-02 The Johns Hopkins University Methods and devices for percutaneous and surgical interventions
US6758836B2 (en) 2002-02-07 2004-07-06 C. R. Bard, Inc. Split tip dialysis catheter
US7771387B2 (en) * 2002-05-17 2010-08-10 Boston Scientific Scimed, Inc. Liquid embolic composition delivery devices and methods
EP1380290A1 (fr) * 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht La voie de la structure cross-béta et sa pertinence thérapeutique
US8425549B2 (en) * 2002-07-23 2013-04-23 Reverse Medical Corporation Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US7309334B2 (en) 2002-07-23 2007-12-18 Von Hoffmann Gerard Intracranial aspiration catheter
US7223253B2 (en) * 2002-07-29 2007-05-29 Gore Enterprise Holdings, Inc. Blood aspiration system and methods of use
US6942686B1 (en) 2002-11-01 2005-09-13 Coaxia, Inc. Regulation of cerebral blood flow by temperature change-induced vasodilatation
US7393339B2 (en) * 2003-02-21 2008-07-01 C. R. Bard, Inc. Multi-lumen catheter with separate distal tips
US20040243095A1 (en) 2003-05-27 2004-12-02 Shekhar Nimkar Methods and apparatus for inserting multi-lumen spit-tip catheters into a blood vessel
US20050085683A1 (en) * 2003-10-15 2005-04-21 Bolling Steven F. Implantable heart assist system and method of applying same
EP1696806B1 (fr) 2003-11-21 2012-08-29 Silk Road Medical, Inc. Appareil de traitement d'artere carotide
US20050131385A1 (en) * 2003-12-12 2005-06-16 Bolling Steven F. Cannulae for selectively enhancing blood flow
US20050182436A1 (en) * 2004-02-18 2005-08-18 Scimed Life Systems, Inc. Apparatus and method for creating working channel through tissue
US8992454B2 (en) 2004-06-09 2015-03-31 Bard Access Systems, Inc. Splitable tip catheter with bioresorbable adhesive
US7445592B2 (en) * 2004-06-10 2008-11-04 Orqis Medical Corporation Cannulae having reduced flow resistance
US20050277870A1 (en) * 2004-06-10 2005-12-15 Robert Pecor Cannula having reduced flow resistance
US8323227B2 (en) 2004-07-02 2012-12-04 C. R. Bard, Inc. Tip configurations for a multi-lumen catheter
US20060004316A1 (en) 2004-07-02 2006-01-05 Difiore Attilio E Reduction of recirculation in catheters
WO2006006163A2 (fr) * 2004-07-12 2006-01-19 Coreolis Inc. Dispositif et procede d'assistance multiple d'organes
US20060211981A1 (en) * 2004-12-27 2006-09-21 Integrated Sensing Systems, Inc. Medical treatment procedure and system in which bidirectional fluid flow is sensed
WO2006089243A2 (fr) 2005-02-16 2006-08-24 University Of Virginia Patent Foundation Catheters a derivation du flux sanguin et procedes de delivrance d'une substance a la vasculature et aux conduits corporels
US20060224110A1 (en) * 2005-03-17 2006-10-05 Scott Michael J Methods for minimally invasive vascular access
US20090202980A1 (en) * 2005-03-21 2009-08-13 Crossbeta Biosciences B.V. Cross-Beta Structure Comprising Amyloid Binding Proteins and Methods for Detection of the Cross-Beta Structure, for Modulating Cross-Beta Structures Fibril Formation and for Modulating Cross-Beta Structure-Mediated Toxicity and Method for Interfering With Blood Coagulation
US20060259066A1 (en) * 2005-04-28 2006-11-16 Euteneuer Charles L Bifurcated artery filter system
EP1910844B1 (fr) 2005-07-13 2012-04-18 Crossbeta Biosciences B.V. Composés de liaison de structures beta-croisées
CA2615078A1 (fr) * 2005-07-13 2007-01-18 Crossbeta Biosciences B.V. Methodes de determination de l'effet d'un traitement sur la teneur d'une proteine a structure croisee-.beta. selection des traitements et leurs utilisations
US8114832B2 (en) * 2005-07-13 2012-02-14 Crossbeta Biosciences B.V. Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
CA2645930A1 (fr) * 2006-03-17 2007-09-27 Crossbeta Biosciences B.V. Procedes de liaison de structures beta croisees avec des molecules chaperonnes
US10632237B2 (en) 2006-10-09 2020-04-28 Minnetronix, Inc. Tangential flow filter system for the filtration of materials from biologic fluids
EP2086573B1 (fr) 2006-10-09 2020-11-25 Neurofluidics, Inc. Système de purification de fluide cérébrospinal
US10850235B2 (en) 2006-10-09 2020-12-01 Minnetronix, Inc. Method for filtering cerebrospinal fluid (CSF) including monitoring CSF flow
JP5290290B2 (ja) 2007-07-18 2013-09-18 シルク・ロード・メディカル・インコーポレイテッド 頚動脈血流の逆流を確立する方法およびシステム
US20090198172A1 (en) * 2008-02-05 2009-08-06 Garrison Michi E Interventional sheath with retention features
US8545432B2 (en) 2009-06-03 2013-10-01 Silk Road Medical, Inc. System and methods for controlling retrograde carotid arterial blood flow
US8858490B2 (en) 2007-07-18 2014-10-14 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
EP2214765A4 (fr) 2007-10-17 2011-08-10 Bard Access Systems Inc Fabrication de cathéters à pointe divisée
US8292841B2 (en) 2007-10-26 2012-10-23 C. R. Bard, Inc. Solid-body catheter including lateral distal openings
US8066660B2 (en) 2007-10-26 2011-11-29 C. R. Bard, Inc. Split-tip catheter including lateral distal openings
US9579485B2 (en) 2007-11-01 2017-02-28 C. R. Bard, Inc. Catheter assembly including a multi-lumen configuration
US8092415B2 (en) 2007-11-01 2012-01-10 C. R. Bard, Inc. Catheter assembly including triple lumen tip
EP2058000A1 (fr) * 2007-11-08 2009-05-13 Crossbeta Biosciences B.V. Compositions immunogènes capables d'activer des cellules T
EP2058001A1 (fr) * 2007-11-08 2009-05-13 Crossbeta Biosciences B.V. Amélioration de l'immunogénicité des antigènes
US10517617B2 (en) 2007-12-20 2019-12-31 Angiodynamics, Inc. Systems and methods for removing undesirable material within a circulatory system utilizing a balloon catheter
US8613717B2 (en) 2007-12-20 2013-12-24 Angiodynamics, Inc. Systems and methods for removing and fragmenting undesirable material within a circulatory system
US20110213290A1 (en) * 2007-12-20 2011-09-01 Vortex Medical Systems and Methods for Removing Undesirable Material Within a Circulatory System
US8506512B2 (en) * 2007-12-20 2013-08-13 Angio Dynamics Systems and methods for removing undesirable material within a circulatory system utilizing a balloon catheter
US8734374B2 (en) * 2007-12-20 2014-05-27 Angiodynamics, Inc. Systems and methods for removing undesirable material within a circulatory system during a surgical procedure
US11589880B2 (en) 2007-12-20 2023-02-28 Angiodynamics, Inc. System and methods for removing undesirable material within a circulatory system utilizing during a surgical procedure
US20110213392A1 (en) * 2007-12-20 2011-09-01 Vortex Medical Systems and Methods for Removing Undesirable Material Within a Circulatory System
WO2009100210A1 (fr) 2008-02-05 2009-08-13 Silk Road Medical, Inc. Système de cathéter d’intervention et procédés
US9402707B2 (en) 2008-07-22 2016-08-02 Neuravi Limited Clot capture systems and associated methods
US8777976B2 (en) 2008-07-22 2014-07-15 Neuravi Limited Clot capture systems and associated methods
US8574245B2 (en) 2008-08-13 2013-11-05 Silk Road Medical, Inc. Suture delivery device
JP2012500049A (ja) 2008-08-13 2012-01-05 シルク・ロード・メディカル・インコーポレイテッド 縫合糸送達デバイス
JP2012513292A (ja) * 2008-12-23 2012-06-14 シルク・ロード・メディカル・インコーポレイテッド 急性虚血性脳卒中の治療方法及び治療システム
WO2010083527A2 (fr) 2009-01-16 2010-07-22 Claret Medical, Inc. Filtre sanguin intravasculaire
US9636205B2 (en) 2009-01-16 2017-05-02 Claret Medical, Inc. Intravascular blood filters and methods of use
US20170202657A1 (en) 2009-01-16 2017-07-20 Claret Medical, Inc. Intravascular blood filters and methods of use
US9326843B2 (en) 2009-01-16 2016-05-03 Claret Medical, Inc. Intravascular blood filters and methods of use
EP2391303A4 (fr) * 2009-01-29 2020-09-09 Boston Scientific Scimed, Inc. Filtre sanguin intra-vasculaire éclairé
WO2010099437A1 (fr) * 2009-02-27 2010-09-02 Silk Road Medical, Inc. Dispositif de pince destiné à la fermeture de vaisseaux
US20100318180A1 (en) * 2009-06-15 2010-12-16 Boston Scientific Scimed, Inc. Multi-layer stent assembly
US8394218B2 (en) 2009-07-20 2013-03-12 Covidien Lp Method for making a multi-lumen catheter having a separated tip section
US8753370B2 (en) * 2009-07-27 2014-06-17 Claret Medical, Inc. Dual endovascular filter and methods of use
KR101116867B1 (ko) * 2009-08-28 2012-03-06 김준홍 관상정맥동과 삼천판막의 조직보호기구, 매듭 전달 기구 및 이들을 포함하는 승모판막 서클라지 시술용 장치
US9662431B2 (en) 2010-02-17 2017-05-30 Flow Forward Medical, Inc. Blood pump systems and methods
US9555174B2 (en) 2010-02-17 2017-01-31 Flow Forward Medical, Inc. Blood pump systems and methods
CN103495219B (zh) 2010-02-17 2017-08-08 弗洛福沃德医药股份有限公司 用来增大静脉总直径的系统和方法
US9131874B2 (en) 2010-04-21 2015-09-15 The Regents Of The University Of Michigan Fluoroscopy-independent, endovascular aortic occlusion system
CN103124785A (zh) * 2010-04-30 2013-05-29 迪亚德克瑟斯公司 在急性护理背景中使用脂蛋白相关磷脂酶a2的方法
WO2012021406A2 (fr) 2010-08-12 2012-02-16 Silk Road Medical, Inc. Systèmes et procédés pour traiter une artère carotide
US20120203265A1 (en) * 2010-10-14 2012-08-09 Heuser Richard R Embolism protection device
WO2012052982A1 (fr) 2010-10-22 2012-04-26 Neuravi Limited Système de mise en prise et de retrait de caillot
WO2012092377A1 (fr) 2010-12-30 2012-07-05 Claret Medical, Inc. Filtres à sang intravasculaires et procédés d'utilisation
WO2014139845A1 (fr) 2013-03-14 2014-09-18 Neuravi Limited Dispositif de retrait d'un caillot occlusif dans un vaisseau sanguin
EP3871617A1 (fr) 2011-03-09 2021-09-01 Neuravi Limited Dispositif de récupération de caillot pour éliminer un caillot d'occlusion d'un vaisseau sanguin
US12076037B2 (en) 2011-03-09 2024-09-03 Neuravi Limited Systems and methods to restore perfusion to a vessel
US11259824B2 (en) 2011-03-09 2022-03-01 Neuravi Limited Clot retrieval device for removing occlusive clot from a blood vessel
US9555216B2 (en) 2011-07-13 2017-01-31 Khoury Medical Devices, Llc Distal perfusion sheath
US9205237B2 (en) 2011-07-13 2015-12-08 Khoury Medical Devices, Llc Single lumen distal perfusion sheath
US9017275B2 (en) 2011-07-13 2015-04-28 Khoury Medical Devices, Llc Distal perfusion sheath
US20130023852A1 (en) * 2011-07-22 2013-01-24 William Joseph Drasler Flow Protection Device
US10779855B2 (en) 2011-08-05 2020-09-22 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
JP2014521462A (ja) 2011-08-05 2014-08-28 シルク・ロード・メディカル・インコーポレイテッド 急性虚血性脳卒中を治療するための方法及びシステム
US8951222B2 (en) * 2011-08-10 2015-02-10 Western Vascular Institute Arterial shunt
JP6190807B2 (ja) 2011-08-17 2017-08-30 フロー フォワード メディカル，インク． 血液ポンプシステムと方法
CN107242890B (zh) 2011-08-17 2021-05-28 爱提奥医药股份有限公司 增加静脉和动脉的总直径的系统和方法
US9168352B2 (en) 2011-12-19 2015-10-27 Cardiacassist, Inc. Dual lumen cannula
WO2013158785A1 (fr) * 2012-04-17 2013-10-24 Claret Medical, Inc. Dispositif de protection contre une embolie
US10342699B2 (en) 2012-08-03 2019-07-09 J.D. Franco & Co., Llc Systems and methods for treating eye diseases
WO2017156333A1 (fr) 2016-03-09 2017-09-14 J.D. Franco & Co. Systèmes et procédés pour traiter des maladies oculaires à l'aide d'un écoulement sanguin rétrograde
US10159479B2 (en) 2012-08-09 2018-12-25 Silk Road Medical, Inc. Suture delivery device
US10258730B2 (en) 2012-08-17 2019-04-16 Flow Forward Medical, Inc. Blood pump systems and methods
US9414752B2 (en) 2012-11-09 2016-08-16 Elwha Llc Embolism deflector
WO2014105873A1 (fr) 2012-12-26 2014-07-03 Stryker Corporation Endoprothèse multicouche
USD748252S1 (en) 2013-02-08 2016-01-26 C. R. Bard, Inc. Multi-lumen catheter tip
US9474882B2 (en) 2013-02-26 2016-10-25 Prytime Medical Devices, Inc. Fluoroscopy-independent balloon guided occlusion catheter and methods
US9642635B2 (en) 2013-03-13 2017-05-09 Neuravi Limited Clot removal device
EP2967611B1 (fr) 2013-03-14 2019-01-16 Neuravi Limited Dispositifs pour l'élimination des obstructions aiguës des vaisseaux sanguins
US9433429B2 (en) 2013-03-14 2016-09-06 Neuravi Limited Clot retrieval devices
US9668741B2 (en) 2013-08-14 2017-06-06 Zoll Circulation, Inc. Aortic occluder with tensioned balloons
EP3043858B1 (fr) 2013-09-09 2022-11-02 Prytime Medical Devices, Inc. Cathéter d'occlusion au profil bas
US9931490B2 (en) 2013-12-17 2018-04-03 Zoll Circulation, Incorporated Control system for arterial catheter
US9737693B2 (en) 2013-12-17 2017-08-22 Zoll Circulation, Inc. Control system for arterial catheter
US9265512B2 (en) 2013-12-23 2016-02-23 Silk Road Medical, Inc. Transcarotid neurovascular catheter
US10285720B2 (en) 2014-03-11 2019-05-14 Neuravi Limited Clot retrieval system for removing occlusive clot from a blood vessel
US9241699B1 (en) 2014-09-04 2016-01-26 Silk Road Medical, Inc. Methods and devices for transcarotid access
US9849229B2 (en) 2014-04-25 2017-12-26 Covidien Lp Split-tip catheter
US10182801B2 (en) 2014-05-16 2019-01-22 Silk Road Medical, Inc. Vessel access and closure assist system and method
US9901722B2 (en) 2014-06-01 2018-02-27 White Swell Medical Ltd System and method for treatment of pulmonary edema
JP6286564B2 (ja) 2014-06-10 2018-02-28 プリタイム・メディカル・デバイシーズ・インコーポレイテッドＰｒｙｔｉｍｅ Ｍｅｄｉｃａｌ Ｄｅｖｉｃｅｓ，Ｉｎｃ． 導管ガイドチップ
US10792056B2 (en) 2014-06-13 2020-10-06 Neuravi Limited Devices and methods for removal of acute blockages from blood vessels
JP6595513B2 (ja) 2014-06-13 2019-10-23 ニューラヴィ・リミテッド 血管からの急性閉塞物の除去のための装置
US10265086B2 (en) 2014-06-30 2019-04-23 Neuravi Limited System for removing a clot from a blood vessel
US10258768B2 (en) 2014-07-14 2019-04-16 C. R. Bard, Inc. Apparatuses, systems, and methods for inserting catheters having enhanced stiffening and guiding features
US11027104B2 (en) 2014-09-04 2021-06-08 Silk Road Medical, Inc. Methods and devices for transcarotid access
US11253278B2 (en) 2014-11-26 2022-02-22 Neuravi Limited Clot retrieval system for removing occlusive clot from a blood vessel
ES2920773T3 (es) 2014-11-26 2022-08-09 Neuravi Ltd Un dispositivo de extracción de coágulos para eliminar un coágulo oclusivo de un vaso sanguíneo
US10617435B2 (en) 2014-11-26 2020-04-14 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
EP3240507A4 (fr) 2014-12-29 2018-12-05 Ocudyne LLC Appareil et procédé pour traiter des maladies oculaires
ES2770321T3 (es) 2015-02-04 2020-07-01 Route 92 Medical Inc Sistema de trombectomía por aspiración rápida
US11065019B1 (en) 2015-02-04 2021-07-20 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
WO2016149653A2 (fr) 2015-03-19 2016-09-22 Prytime Medical Devices, Inc. Système et procédé pour cathéter d'occlusion à ballonnet à faible encombrement
ES2759930T3 (es) 2015-04-10 2020-05-12 Silk Road Medical Inc Métodos y sistemas para establecer un flujo sanguíneo arterial carotídeo retrógrado
US9566144B2 (en) 2015-04-22 2017-02-14 Claret Medical, Inc. Vascular filters, deflectors, and methods
EP4427791A2 (fr) 2015-05-11 2024-09-11 White Swell Medical Ltd Systèmes de réduction de la pression au niveau d'un écoulement sortant d'un conduit
US11147540B2 (en) 2015-07-01 2021-10-19 Minnetronix, Inc. Introducer sheath and puncture tool for the introduction and placement of a catheter in tissue
WO2017027639A1 (fr) * 2015-08-12 2017-02-16 TDL Innovations, LLC Système de cathéter d'aspiration orientable
ES2856599T3 (es) 2015-12-04 2021-09-27 Minnetronix Inc Sistemas de acondicionamiento de fluido cerebrospinal
EP3448487A4 (fr) 2016-04-29 2020-04-29 Flow Forward Medical, Inc. Embouts de conduits et systèmes et procédés d'utilisation
EP3463106B1 (fr) 2016-06-02 2023-10-25 Prytime Medical Devices, Inc. Système de cathéter d'occlusion contenant un ballon a profil reduit
BR112019003113A2 (pt) 2016-08-17 2019-05-21 Neuravi Limited sistema de remoção de coágulo para remover coágulo oclusivo de um vaso sanguíneo
AU2017324233A1 (en) 2016-09-06 2019-04-04 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
US20220240955A1 (en) * 2016-09-07 2022-08-04 Daniel Ezra Walzman Methods and devices to ameliorate vascular obstruction
AU2017330410A1 (en) 2016-09-24 2019-04-11 J.D. Franco & Co., Llc Systems and methods for single puncture percutaneous reverse blood flow
IL295266A (en) 2016-11-01 2022-10-01 White Swell Medical Ltd Systems and methods for treating excess fluids
WO2018106858A1 (fr) 2016-12-08 2018-06-14 J.D. Franco & Company Procédés et dispositifs de traitement d'un œil à l'aide d'un filtre
EP3568190B1 (fr) 2017-01-12 2023-11-22 The Regents of the University of California Augmentation de perfusion endovasculaire pour soins intensifs
EP3573538A4 (fr) 2017-01-25 2020-12-16 J.D. Franco & Co., LLC Dispositifs d'accès et de fermeture de vaisseau sanguin et procédés d'utilisation associés
EP3585304B1 (fr) 2017-02-22 2022-04-27 Boston Scientific Scimed, Inc. Systèmes de protection du système vasculaire cérébral
CA3054771A1 (fr) 2017-03-02 2018-09-07 White Swell Medical Ltd Systemes et methodes pour reduire la pression d'un debit sortant d'une conduite
US11406393B2 (en) 2017-03-19 2022-08-09 White Swell Medical Ltd Methods and devices for reducing pressure
CN110769749B (zh) 2017-04-21 2023-05-09 加利福尼亚大学董事会 用于部分主动脉闭塞的主动脉流量计和泵
US10898212B2 (en) 2017-05-07 2021-01-26 J.D. Franco & Co., Llc Devices and methods for treating an artery
US10779929B2 (en) 2017-10-06 2020-09-22 J.D. Franco & Co., Llc Treating eye diseases by deploying a stent
US11191630B2 (en) 2017-10-27 2021-12-07 Claret Medical, Inc. Systems and methods for protecting the cerebral vasculature
US10398880B2 (en) 2017-11-02 2019-09-03 J.D. Franco & Co., Llc Medical systems, devices, and related methods
WO2019089385A1 (fr) 2017-11-02 2019-05-09 Silk Road Medical, Inc. Gaine fenêtrée pour protection embolique pendant la revascularisation transcarotidienne de l'artère carotide
US10758254B2 (en) 2017-12-15 2020-09-01 J.D. Franco & Co., Llc Medical systems, devices, and related methods
EP4212127A1 (fr) 2017-12-19 2023-07-19 Boston Scientific Scimed, Inc. Système de protection du système vasculaire cérébral
US11478249B2 (en) * 2018-02-23 2022-10-25 J.D. Franco & Co., Llc Ophthalmic artery therapy under reverse flow
EP4400086A3 (fr) 2018-04-26 2024-09-25 Boston Scientific Scimed, Inc. Systèmes et procédés de protection du système vasculaire cérébral
JP2021523793A (ja) 2018-05-17 2021-09-09 ルート９２メディカル・インコーポレイテッドＲｏｕｔｅ ９２ Ｍｅｄｉｃａｌ， Ｉｎｃ． 吸引カテーテルシステム及び使用方法
US12011172B2 (en) 2018-08-06 2024-06-18 Prytime Medical Devices, Inc. Occlusion catheter system for full or partial occlusion
CN112930152B (zh) 2018-08-21 2024-09-24 波士顿科学国际有限公司 保护脑血管的系统和方法
US10842498B2 (en) 2018-09-13 2020-11-24 Neuravi Limited Systems and methods of restoring perfusion to a vessel
US11406416B2 (en) 2018-10-02 2022-08-09 Neuravi Limited Joint assembly for vasculature obstruction capture device
US10799688B2 (en) 2018-12-31 2020-10-13 J.D. Franco & Co., Llc Intravascular devices, systems, and methods to address eye disorders
US11717652B2 (en) 2019-02-26 2023-08-08 White Swell Medical Ltd Devices and methods for treating edema
US11660426B2 (en) 2019-02-26 2023-05-30 White Swell Medical Ltd Devices and methods for treating edema
US11793996B2 (en) 2019-02-26 2023-10-24 White Swell Medical Ltd Devices and methods for treating edema
US11931560B2 (en) 2019-02-26 2024-03-19 White Swell Medical Ltd Devices and methods for treating edema
US11724095B2 (en) 2019-02-26 2023-08-15 White Swell Medical Ltd Devices and methods for treating edema
JP7483409B2 (ja) 2019-03-04 2024-05-15 ニューラヴィ・リミテッド 作動血塊回収カテーテル
EP4427686A2 (fr) 2019-09-11 2024-09-11 Neuravi Limited Cathéter buccal extensible
US11712231B2 (en) 2019-10-29 2023-08-01 Neuravi Limited Proximal locking assembly design for dual stent mechanical thrombectomy device
US11839725B2 (en) 2019-11-27 2023-12-12 Neuravi Limited Clot retrieval device with outer sheath and inner catheter
US11779364B2 (en) 2019-11-27 2023-10-10 Neuravi Limited Actuated expandable mouth thrombectomy catheter
US11517340B2 (en) 2019-12-03 2022-12-06 Neuravi Limited Stentriever devices for removing an occlusive clot from a vessel and methods thereof
US11648020B2 (en) 2020-02-07 2023-05-16 Angiodynamics, Inc. Device and method for manual aspiration and removal of an undesirable material
US11633198B2 (en) 2020-03-05 2023-04-25 Neuravi Limited Catheter proximal joint
US11944327B2 (en) 2020-03-05 2024-04-02 Neuravi Limited Expandable mouth aspirating clot retrieval catheter
AU2021239935A1 (en) 2020-03-16 2022-10-06 Certus Critical Care, Inc. Blood flow control devices, systems, and methods and error detection thereof
US11883043B2 (en) 2020-03-31 2024-01-30 DePuy Synthes Products, Inc. Catheter funnel extension
US11759217B2 (en) 2020-04-07 2023-09-19 Neuravi Limited Catheter tubular support
US11717308B2 (en) 2020-04-17 2023-08-08 Neuravi Limited Clot retrieval device for removing heterogeneous clots from a blood vessel
US11871946B2 (en) 2020-04-17 2024-01-16 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US11730501B2 (en) 2020-04-17 2023-08-22 Neuravi Limited Floating clot retrieval device for removing clots from a blood vessel
US11737771B2 (en) 2020-06-18 2023-08-29 Neuravi Limited Dual channel thrombectomy device
US11937836B2 (en) 2020-06-22 2024-03-26 Neuravi Limited Clot retrieval system with expandable clot engaging framework
US11395669B2 (en) 2020-06-23 2022-07-26 Neuravi Limited Clot retrieval device with flexible collapsible frame
US11439418B2 (en) 2020-06-23 2022-09-13 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US11864781B2 (en) 2020-09-23 2024-01-09 Neuravi Limited Rotating frame thrombectomy device
US11937837B2 (en) 2020-12-29 2024-03-26 Neuravi Limited Fibrin rich / soft clot mechanical thrombectomy device
US12029442B2 (en) 2021-01-14 2024-07-09 Neuravi Limited Systems and methods for a dual elongated member clot retrieval apparatus
US11872354B2 (en) 2021-02-24 2024-01-16 Neuravi Limited Flexible catheter shaft frame with seam
US12064130B2 (en) 2021-03-18 2024-08-20 Neuravi Limited Vascular obstruction retrieval device having sliding cages pinch mechanism
US12102330B2 (en) 2021-03-18 2024-10-01 Prytime Medical Devices, Inc. Vascular occlusion catheter for partial occlusion or full occlusion
US11974764B2 (en) 2021-06-04 2024-05-07 Neuravi Limited Self-orienting rotating stentriever pinching cells
US11937839B2 (en) 2021-09-28 2024-03-26 Neuravi Limited Catheter with electrically actuated expandable mouth
US12011186B2 (en) 2021-10-28 2024-06-18 Neuravi Limited Bevel tip expandable mouth catheter with reinforcing ring

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619639A (en) * 1980-02-05 1986-10-28 Asahi Medical Co., Ltd. Method and apparatus for low pressure filtration of plasma from blood
US5348015A (en) * 1992-09-17 1994-09-20 Applied Physiology And Medicine Method and apparatus for ultrasonically detecting, counting and/or characterizing emboli
US5374239A (en) * 1992-08-04 1994-12-20 Metatech Corporation Arterial shunt with blood flow indicator
US5827222A (en) * 1990-10-10 1998-10-27 Life Resuscitation Technologies, Inc. Method of treating at least one of brain and associated nervous tissue injury

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34077A (en) * 1862-01-07 Improvement in weighing-registers
US4248224A (en) * 1978-08-01 1981-02-03 Jones James W Double venous cannula
US4610656A (en) 1984-08-21 1986-09-09 Mehealus Partnership Fully portable semi-automatic mechanical heart-lung substitution system and method
US5226430A (en) * 1984-10-24 1993-07-13 The Beth Israel Hospital Method for angioplasty
US4731055A (en) * 1986-08-25 1988-03-15 Becton, Dickinson And Company Blood flow conduit
US4712551A (en) * 1986-10-14 1987-12-15 Rayhanabad Simon B Vascular shunt
US4804359A (en) * 1987-10-23 1989-02-14 Research Medical, Inc. Cardiovascular cannula and obturator
USRE34077E (en) 1988-05-02 1992-09-22 Cryomedical Sciences, Inc. Blood substitute
US5458574A (en) * 1994-03-16 1995-10-17 Heartport, Inc. System for performing a cardiac procedure
US5478309A (en) * 1994-05-27 1995-12-26 William P. Sweezer, Jr. Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery
US5695519A (en) * 1995-11-30 1997-12-09 American Biomed, Inc. Percutaneous filter for carotid angioplasty
US6048331A (en) * 1996-05-14 2000-04-11 Embol-X, Inc. Cardioplegia occluder
US6022336A (en) * 1996-05-20 2000-02-08 Percusurge, Inc. Catheter system for emboli containment
US20010049517A1 (en) * 1997-03-06 2001-12-06 Gholam-Reza Zadno-Azizi Method for containing and removing occlusions in the carotid arteries
US5876367A (en) * 1996-12-05 1999-03-02 Embol-X, Inc. Cerebral protection during carotid endarterectomy and downstream vascular protection during other surgeries
US6699231B1 (en) * 1997-12-31 2004-03-02 Heartport, Inc. Methods and apparatus for perfusion of isolated tissue structure
US6042559A (en) 1998-02-24 2000-03-28 Innercool Therapies, Inc. Insulated catheter for selective organ perfusion
US6736790B2 (en) * 1998-02-25 2004-05-18 Denise R. Barbut Method and system for selective or isolated integrate cerebral perfusion and cooling
AR017498A1 (es) * 1998-03-13 2001-09-12 Arteria Medical Science Llc Dispositivo para proteccion contra embolizaciones, en angioplastia de carotida
US6908474B2 (en) * 1998-05-13 2005-06-21 Gore Enterprise Holdings, Inc. Apparatus and methods for reducing embolization during treatment of carotid artery disease
US6165199A (en) * 1999-01-12 2000-12-26 Coaxia, Inc. Medical device for removing thromboembolic material from cerebral arteries and methods of use
US6161547A (en) * 1999-01-15 2000-12-19 Coaxia, Inc. Medical device for flow augmentation in patients with occlusive cerebrovascular disease and methods of use
US6146370A (en) * 1999-04-07 2000-11-14 Coaxia, Inc. Devices and methods for preventing distal embolization from the internal carotid artery using flow reversal by partial occlusion of the external carotid artery

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619639A (en) * 1980-02-05 1986-10-28 Asahi Medical Co., Ltd. Method and apparatus for low pressure filtration of plasma from blood
US5827222A (en) * 1990-10-10 1998-10-27 Life Resuscitation Technologies, Inc. Method of treating at least one of brain and associated nervous tissue injury
US5374239A (en) * 1992-08-04 1994-12-20 Metatech Corporation Arterial shunt with blood flow indicator
US5348015A (en) * 1992-09-17 1994-09-20 Applied Physiology And Medicine Method and apparatus for ultrasonically detecting, counting and/or characterizing emboli

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1156848A1 (fr) * 1999-03-01 2001-11-28 Coaxia, Inc. Dispositifs et procedes d'occlusion aortique partielle pour augmenter l'irrigation sanguine cerebrale
EP1156848A4 (fr) * 1999-03-01 2007-06-27 Coaxia Inc Dispositifs et procedes d'occlusion aortique partielle pour augmenter l'irrigation sanguine cerebrale
US7993324B2 (en) 1999-03-01 2011-08-09 Coaxia, Inc. Cerebral perfusion augmentation
US8888740B2 (en) 2001-04-24 2014-11-18 Zoll Circulation, Inc. Partial aortic occlusion devices and methods for cerebral perfusion augmentation
WO2006026805A1 (fr) * 2004-09-07 2006-03-16 Droneon Pty Limited Dispositifs et systemes d'acces peripherique
US7766853B2 (en) 2004-09-07 2010-08-03 Droneon Pty Limited Peripheral access devices and systems
AU2005282202B2 (en) * 2004-09-07 2010-09-09 Droneon Pty Limited Peripheral access devices and systems
AU2010212369B2 (en) * 2004-09-07 2012-06-14 Droneon Pty Limited Peripheral access devices and systems
US8419672B2 (en) 2004-09-07 2013-04-16 Droneon Pty Limited Peripheral access devices and systems
US9078982B2 (en) 2007-11-07 2015-07-14 Rodney J. Lane Systems, methods and devices for circulatory access

Also Published As

Publication number Publication date
US6878140B2 (en) 2005-04-12
US20030199802A1 (en) 2003-10-23
US6161547A (en) 2000-12-19
US6558356B2 (en) 2003-05-06
US20020156455A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
US6161547A (en) Medical device for flow augmentation in patients with occlusive cerebrovascular disease and methods of use
US6312444B1 (en) Medical device for removing thromboembolic material from cerebral arteries and methods of use
US6146370A (en) Devices and methods for preventing distal embolization from the internal carotid artery using flow reversal by partial occlusion of the external carotid artery
US6837881B1 (en) Devices and methods for preventing distal embolization using flow reversal by partial occlusion of the brachiocephalic artery
US8221383B2 (en) Devices and methods for preventing distal embolization from the vertebrobasilar artery using flow reversal
US9744337B2 (en) Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature
US6044845A (en) Methods and systems for treating ischemia
US6435189B1 (en) Methods and systems for treating ischemia
JP3535098B2 (ja) 弁修復手術のための経皮濾過カテーテル
Novelline Percutaneous transluminal angioplasty: newer applications
US20020169436A1 (en) Percutaneous method of preventing distal embolisation while maintaining adequate distal perfusion in percutaneous interventional procedures
AU6512000A (en) Method and apparatus for differentially perfusing a patient during cardiopulmonary bypass
US6848448B1 (en) Devices and methods for cerebral perfusion augmentation
Parodi et al. Minimizing complications of carotid stenting
Aoi¹ et al. Acute Limb Ischemia
Zhao et al. Zaiping Jing, Huajuan Mao, Meiqin Shi, Junmin Bao
SAAB et al. Indigo® System for Thromboembolic Disease
Al-Kutoubi Radiology of access
Brown Interventions to restore or maintain access patency
BOSIERS et al. WORKING PRINCIPLE OF DISTAL OCCLUSION DEVICES

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase